Patents by Inventor Julien SALDO

Julien SALDO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210220316
    Abstract: The present invention provides aqueous ophthalmic compositions in the form of solution comprising hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester and macrogol 15 hydroxystearate as the only solubilizing agent, and a method for their preparation.
    Type: Application
    Filed: March 29, 2021
    Publication date: July 22, 2021
    Inventors: Frédéric PILOTAZ, Alan L. WEINER, Marina DO, Julien SALDO
  • Patent number: 11020368
    Abstract: The present invention provides aqueous ophthalmic compositions in the form of solution comprising hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester and macrogol 15 hydroxystearate as the only solubilizing agent, and a method for their preparation.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: June 1, 2021
    Assignee: NICOX S.A.
    Inventors: Frédéric Pilotaz, Alan L. Weiner, Marina Do, Julien Saldo
  • Publication number: 20210128458
    Abstract: The present invention provides aqueous ophthalmic compositions in the form of solution comprising hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester and macrogol 15 hydroxystearate as the only solubilizing agent, and a method for their preparation.
    Type: Application
    Filed: January 11, 2021
    Publication date: May 6, 2021
    Inventors: Frédéric PILOTAZ, Alan L. WEINER, Marina DO, Julien SALDO
  • Publication number: 20200206176
    Abstract: The present invention provides aqueous ophthalmic compositions in the form of solution comprising hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester and macrogol 15 hydroxystearate as the only solubilizing agent, and a method for their preparation.
    Type: Application
    Filed: March 11, 2020
    Publication date: July 2, 2020
    Inventors: Frédéric PILOTAZ, Alan L. WEINER, Marina DO, Julien SALDO
  • Patent number: 10688073
    Abstract: The present invention provides aqueous ophthalmic compositions in the form of solution comprising hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester and macrogol 15 hydroxystearate as the only solubilizing agent, and a method for their preparation.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: June 23, 2020
    Assignee: NICOX SA
    Inventors: Frédéric Pilotaz, Alan L. Weiner, Marina Do, Julien Saldo
  • Publication number: 20200016108
    Abstract: The present invention provides aqueous ophthalmic compositions in the form of solution comprising hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester and macrogol 15 hydroxystearate as the only solubilizing agent, and a method for their preparation.
    Type: Application
    Filed: July 10, 2019
    Publication date: January 16, 2020
    Inventors: Frédéric PILOTAZ, Alan L. WEINER, Marina DO, Julien SALDO